Evaxion Biotech Stock Forward View - 8 Period Moving Average

EVAX Stock  USD 4.34  0.27  6.63%   
8 Period Moving Average is applied to Evaxion Biotech AS's daily closing prices, and the resulting forecast is presented with accuracy metrics. Wide deviation between fitted and observed values suggests the model's assumptions may not match current market conditions. The 8 Period Moving Average model projects Evaxion Biotech at 4.38 for the next trading day, above the most recent closing price. This 8 Period Moving Average output is provided as analytical reference and does not constitute a trading recommendation.
The eight-period moving average forecast for Evaxion Biotech replaces each daily closing price with the mean of that value and the eight preceding observations. This wider window produces a smoother series that filters out short-term volatility.

8 Period Moving Average Price Forecast For the 11th of May 2026

Over a 90-day horizon, the 8 Period Moving Average model forecasts Evaxion Biotech at 4.38 for the next trading day, with a mean absolute deviation of 0.19 , mean absolute percentage error of 0.05 , and sum of absolute errors of 10.19 .
This represents a tight forecast with good short-term tracking of Evaxion Biotech's price movement. This output is intended for short-term analytical reference.

Stock Forecast Pattern

Backtest Evaxion Biotech  Evaxion Biotech Price Prediction  Research Analysis  

Forecasted Value

The next-day forecast range for Evaxion Biotech defines statistically derived downside and upside boundaries based on model performance. The model places downside around 0.04 and upside around 9.06 for the next session. The wide range indicates elevated uncertainty in short-term projections.
Market Value
4.34
4.38
Expected Value
9.06

Model Predictive Factors

The table below summarizes the 8 Period Moving Average model's error metrics for Evaxion Biotech stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.
AICAkaike Information Criteria100.7282
BiasArithmetic mean of the errors -0.0851
MADMean absolute deviation0.1922
MAPEMean absolute percentage error0.0488
SAESum of the absolute errors10.1875
The eight-period window effectively dampens daily peaks and troughs in Evaxion Biotech AS price data, making the underlying trend more visible. However, the model can only be used reliably for one or two periods ahead. A flat forecast line in a trending market indicates the smoothing window is too wide for the current price dynamics.

Other Forecasting Options for Evaxion Biotech

Evaxion Biotech's daily price returns decompose into trend, seasonal, and residual components. Divergence between short-term and long-term averages in Evaxion Biotech often signals an upcoming reversal or acceleration.

Evaxion Biotech Related Equities

These related stocks within the Health Care space give benchmarks for judging Evaxion Biotech's results, margins, and growth trend. Profit comparisons show whether Evaxion Biotech earns above or below average returns next to its peers.
 Risk & Return  Correlation

Evaxion Biotech Market Strength Events

Market strength indicators for Evaxion Biotech stock provide a framework for assessing security responsiveness. A rising Accumulation/Distribution line alongside rising price confirms institutional buying interest in Evaxion Biotech.

Evaxion Biotech Risk Indicators

Assessing Evaxion Biotech's risk indicators is a structured way to evaluate the risk-return trade-off for evaxion biotech stock. The level of risk embedded in Evaxion Biotech's feeds directly into exposure calibration.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Evaxion Biotech Short Properties

Short sentiment tied to Evaxion Biotech AS matters because heavier bearish pressure can change how quickly future price expectations become unstable. A disciplined short-interest review can make timing decisions more informed under rising skepticism.
Common Stock Shares Outstanding6.41 million
Cash And Short Term Investments23.23 million

More Resources for Evaxion Biotech Stock Analysis

Understanding Evaxion Biotech AS starts with reviewing its financial statements and long-term patterns. Additional context for Evaxion Biotech AS Stock is provided in the reports below: